Spiration® Valve System (SVS)

FDA Premarket Approval P180007 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of 180 day no fee post-approval study (pas) revisions

DeviceSpiration® Valve System (SVS)
Generic NameValve, Pulmonary
ApplicantGyrus ACMI, Inc.
Date Received2020-10-21
Decision Date2020-12-23
Product CodeNJK 
Advisory CommitteeAnesthesiology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product No
Applicant Address Gyrus ACMI, Inc. 6675 185th Avenue Ne redmond, WA 98052

Supplemental Filings

Supplement NumberDateSupplement Type
P180007Original Filing
S007 2020-10-21 Normal 180 Day Track No User Fee
S005 2019-11-18 Normal 180 Day Track
S003 2018-12-26 Normal 180 Day Track No User Fee
S002 2018-12-26 Normal 180 Day Track No User Fee


Device IDPMASupp
00896506002323 P180007 000
00896506002316 P180007 000
00896506002309 P180007 000
00896506002293 P180007 000
00896506002286 P180007 000
00896506002279 P180007 000

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.